Journal of the American Society of Hypertension
Volume 3, Issue 6 , Pages 395-402, November 2009

An evaluation of the efficacy of olmesartan medoxomil in Black patients with hypertension

  • Thomas D. Giles, MD

      Affiliations

    • Tulane University School of Medicine, New Orleans, Louisiana, USA
    • Corresponding Author InformationCorresponding author: Thomas D. Giles, MD, Tulane University School of Medicine, 542 Tulane Avenue, Room 331, New Orleans, Louisiana 70112. Tel: 504-834-8668; fax: 504-836-0822.
    • ,
  • Suzanne Oparil, MD

      Affiliations

    • University of Alabama School of Medicine at Birmingham, Birmingham, Alabama, USA
    • ,
  • Antonia Wang, PhD

      Affiliations

    • Daiichi Sankyo, Inc., Parsippany, New Jersey, USA
    • ,
  • Robert Dubiel, PharmD

      Affiliations

    • Daiichi Sankyo, Inc., Parsippany, New Jersey, USA

Received 10 March 2009; accepted 16 September 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supported by Daiichi Sankyo, Inc. Dr. Thomas D. Giles received grant/research support from Novartis. Dr. Giles serves as a consultant for Novartis, Forest Laboratories, Daiichi Sankyo, Inc., sanofi-aventis, Bristol-Myers Squibb, and NicOx. Dr. Suzanne Oparil is the recipient of grants-in-aid from Daiichi Sankyo, Inc., Forest Laboratories, Gilead, Novartis, Pfizer, and Takeda. Dr. Oparil is a consultant for Boehringer Ingelheim, Daiichi Sankyo, Inc., NicOx, Novartis, sanofi-aventis, and The Salt Institute. Drs. Antonia Wang and Robert Dubiel are both employees of Daiichi Sankyo, Inc.

PII: S1933-1711(09)00129-6

doi:10.1016/j.jash.2009.09.002

Journal of the American Society of Hypertension
Volume 3, Issue 6 , Pages 395-402, November 2009

Article Tools

* Image Usage & Resolution